Sort
46,585 grants matching “heart failure”
Modulation of Mitofusin Activity to Treat Heart Disease
$647,649Richard N Kitsis · Albert Einstein College Of Medicine · R01 · FY2022 · HL
Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation
$647,639Paul Tang · Mayo Clinic Rochester · R01 · FY2025 · HL
Neurochemical Assessment of Sleep Apnea using Accelerated MR Spectroscopic Imaging
$647,634Michael Albert Thomas · University Of California Los Angeles · R56 · FY2016 · HL
Emotional Exposure and Cognitive Behavioral Therapies for Fibromyalgia
$647,593Mark A Lumley · Wayne State University · R01 · FY2011 · AR
Cleveland COPE-AKI Clinical Center
$647,585Emilio Daniel Poggio · Cleveland Clinic Lerner Com-Cwru · U01 · FY2023 · DK
The Southeastern Acute Kidney Injury (SEAK) Alliance for the COPE-AKI Consortium
$647,584Edward D Siew · Vanderbilt University Medical Center · U01 · FY2023 · DK
A nutrition-based approach to reduce heart disease risk among overweight African Americans: Use of soul food plant-based or omnivorous diets to address cardiovascular disease
$647,576Gabrielle Michelle Turner-McGrievy · University Of South Carolina At Columbia · R01 · FY2018 · HL
A Role of PKG1a and Inhibitors of cGMP Phosphodiesterase in Post MI VT in Mouse Models for Type II Diabetes and Metabolic Syndrome
$647,562Jonas Bernard Galper · Tufts Medical Center · R01 · FY2023 · HL
A Systems Approach to Dissect Genetic Basis of Heart Failure
$647,530Yibin Wang · University Of California Los Angeles · R01 · FY2015 · HL
Ca signaling cross-talk from SR to mitochondria in heart muscle
$647,488Pei-Hui Lin · Ohio State University · R01 · FY2021 · HL
A Randomized Trial of Gamification and Coaching to Improve Mobility after Hospitalization
$647,413Scott Ryan Greysen · University Of Pennsylvania · R01 · FY2024 · AG
FOG2 isoforms in Coronary Microvascular Disease
$647,411Marie A Guerraty · University Of Pennsylvania · R01 · FY2025 · HL
Engineering of biomaterials with controlled biomolecule delivery for cardiovascular applications
$647,359Monica T Hinds · Oregon Health & Science University · R01 · FY2024 · HL
Ketones, Muscle Metabolism, and SGLT2 Inhibitors
$647,334Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2023 · DK
SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis
$647,274Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2024 · DK
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
$647,162Robert Scott Ross · University Of California, San Diego · R01 · FY2015 · HL
Modulation of Protective RAS-GPCR Pathways in Aortic Disease
$647,156Sadashiva S. Karnik · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL
Anti-inflammatory therapy to augment CFTR rescue in CF patients
$647,107Matthias A Salathe · University Of Kansas Medical Center · R01 · FY2020 · HL
Advanced Glycation End-Products in Human Myocardium
$647,087Martin M Lewinter · University Of Vermont & St Agric College · R01 · FY2011 · HL
Optimizing Recovery prediction after Cardiac Arrest (ORCA)
$646,981Jonathan Elmer · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · NS
A system approach to the analysis of Heterotaxy Candidate Genes
$646,936Mustafa K Khokha · Yale University · R01 · FY2020 · HD
Tissue-engineered pulmonic valve grown from human cells for pediatric patients
$646,892Robert T Tranquillo · University Of Minnesota · R01 · FY2015 · HL
Language Processing in Context Following Traumatic Brain Injury
$646,875Melissa C Duff · Vanderbilt University Medical Center · R01 · FY2024 · DC
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH
$646,874You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · HL
Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction
$646,794Hossein Ardehali · Northwestern University At Chicago · R01 · FY2018 · HL